Baheal Pharma Group Acquires 25 Million Shares of BIOSTAR PHARM-B at HK$4 Each
Stock News
Jul 21
According to the latest data from the Hong Kong Stock Exchange, on July 16th, Baheal Pharma Group Co., Ltd. increased its stake in BIOSTAR PHARM-B (HKEX: 02563) by 25 million shares. The transaction was executed at a price of HK$4 per share, amounting to a total consideration of HK$100 million.
Following this acquisition, the group's latest shareholding stands at 29.1708 million shares, representing a 7.49% ownership stake.
The transaction involved other related parties, including Baheal Wellness Industry International Trading Limited, Qingdao Baheal Medical Inc., Fu Gang, Beijing Baiyang Huikang Technology Innovation Development Co., Ltd., and Beijing Baiyang Tongxing Management Consulting Co., Ltd.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.